Clinical Trials Logo

Clinical Trial Summary

NEMO is a multicentre pan European clinical trial with the aim to develop new treatment strategies for the treatment of neonatal seizures using the loop diuretic bumetanide. There is evidence that bumetanide improves GABAergic function of the current standard drug, phenobarbitone. Bumetanide has been used as a diuretic in term and preterm babies for around thirty years. This trial should confirm that Bumetanide in addition to standard treatment will result in better seizures control.


Clinical Trial Description

n/a


Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01434225
Study type Interventional
Source Great Ormond Street Hospital for Children NHS Foundation Trust
Contact
Status Completed
Phase Phase 1/Phase 2
Start date August 2011
Completion date June 2013

See also
  Status Clinical Trial Phase
Terminated NCT01089504 - Prophylactic Phenobarbital After Neonatal Seizures Phase 4
Terminated NCT02550028 - Levetiracetam Treatment of Neonatal Seizures Phase 1/Phase 2
Completed NCT02789176 - Continued Anticonvulsants After Resolution of Neonatal Seizures: a Patient-centered Comparative Effectiveness Study
Not yet recruiting NCT02602015 - Levetiracetam Treatment of Neonatal Seizures Phase 1/Phase 2
Terminated NCT01475656 - Efficacy of Keppra for Neonatal Seizures N/A
Recruiting NCT03107507 - Efficacy of Levetiracetam in Control of Neonatal Seizures Guided by an EEG Phase 4
Completed NCT01720667 - Efficacy of Intravenous Levetiracetam in Neonatal Seizures Phase 1/Phase 2
Recruiting NCT05079971 - EAGLET: EEG vs aEEG to Improve the Diagnosis of neonataL Seizures and Epilepsy N/A
Completed NCT02229123 - Levetiracetam Treatment of Neonatal Seizures: Safety and Efficacy Phase II Study Phase 2
Completed NCT02160171 - ANSeR- The Algorithm for Neonatal Seizure Recognition Study N/A